Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05999123 · ClinicalTrials.gov registry record
Menstrual Cycle Study
A clinical trial of Menstruation and Ovulation, sponsored by Fitbit.
- Completed
- Registry status
- 143
- Enrollment target
- 1
- Study location
NCT05999123: Completed study of Menstruation and Ovulation, sponsored by Fitbit.
NCT05999123 is a study of Menstruation and Ovulation that has completed, run by Fitbit. The registered enrollment target is 143 participants, below the 166,711-participant average among 3 other Menstruation trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05999123, a study of Menstruation and Ovulation, has completed, sponsored by Fitbit.
- COMPLETED
- Registry status
- 143 participants
- Enrollment target
- 1
- Study location
Study Summary
A data collection study to develop algorithms to estimate menstrual cycle phases.
Primary Outcome
The algorithm's estimated ovulation day compared to the reference urinary ovulation predictor kits (OPK).
Conditions Studied
Study Locations (1)
California
- Artemis Headlands LLC (Artemis Institute for Clinical Research) - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 143 participants |
| Start Date | 2023-07-25 |
| Est. Completion | 2024-08-30 |
What the finished NCT05999123 record still lists
NCT05999123 is an observational study that tracks outcomes without assigning an intervention. The registered 143 participants enrollment target is mid-sized for trials with a published cap, below the 166,711-participant average among 3 other Menstruation trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Menstruation appearing as the primary indexed condition, and to 0 interventions.
NCT05999123 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05999123 about?
NCT05999123 is a clinical study titled "Menstrual Cycle Study". A data collection study to develop algorithms to estimate menstrual cycle phases.
What is the current status of trial NCT05999123?
This trial is currently completed. The enrollment target is 143 participants. The study started on 2023-07-25. Estimated completion is 2024-08-30.
What conditions does trial NCT05999123 study?
This clinical trial studies the following conditions: Menstruation, Ovulation.
Who is sponsoring clinical trial NCT05999123?
This trial is sponsored by Fitbit, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05999123 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Menstruation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI